tiprankstipranks
Seres Therapeutics (MCRB)
NASDAQ:MCRB

Seres Therapeutics (MCRB) Technical Analysis

824 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Seres Therapeutics is a Sell.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 0.81, while Seres Therapeutics’s (MCRB) share price is $0.732, making it a Sell.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 0.95, while Seres Therapeutics’s (MCRB) share price is $0.732, making it a Sell.

Seres Therapeutics (MCRB) Pivot Points

Apr 25, 2024, 01:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.69
0.71
0.73
0.76
0.78
0.80
0.83
Fibonacci
0.71
0.73
0.74
0.76
0.78
0.79
0.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

Apr 25, 2024, 01:03 PM
Period
Simple
Exponential
MA5
0.75Sell
0.75Sell
MA10
0.76Sell
0.76Sell
MA20
0.78Sell
0.81Sell
MA50
0.97Sell
0.95Sell
MA100
1.08Sell
1.27Sell
MA200
2.15Sell
2.35Sell
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 0.76, while Seres Therapeutics’s (MCRB) share price is $0.732, making it a Sell.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 1.27, while Seres Therapeutics’s (MCRB) share price is $0.732, making it a Sell.
Seres Therapeutics’s (MCRB) stock price is $0.732 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 0.97, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $0.732 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 1.08, creating a Sell signal.
Seres Therapeutics’s (MCRB) stock price is $0.732 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 2.15, creating a Sell signal.

Seres Therapeutics (MCRB) Technical Indicators

Apr 25, 2024, 01:03 PM
Name
Value
Implied Action
RSI (14)
35.92
Neutral
STOCH (9,6)
36.59
Neutral
STOCHRSI (14)
27.97
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
28.86
Neutral
Williams %R
-86.01
Buy
CCI (14)
-138.68
Buy
ATR (14)
0.06
-
Ultimate Oscillator
38.06
Neutral
ROC
-3.95
Sell
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 35.92, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 28.86, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is -138.68, creating a Buy signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is -3.95, creating a Sell signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Strong Sell.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 35.92, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is -0.07, which suggests MCRB is a Sell.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 0.75, which suggests MCRB is a Sell.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 0.78, which suggests MCRB is a Sell.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 0.97, which suggests MCRB is a Sell.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 2.15, which suggests MCRB is a Sell.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -86.01, which suggests MCRB is a Buy.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is -138.68, which suggests MCRB is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis